Xlife Sciences AG / Key word(s): Letter of Intent/PartnershipXlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases 20.12.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) and Quant Biomar.
Rallybio Corporation (RLYB) Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Preliminary Data Support RLYB212 Once Monthly Subcutaneous Dosing in Phase 2 Study RLYB212 Toxicology Package Complete, Including Maternal-Fetal Toxicology; Key Activity to Support Phase 2.
POTSDAM — November is Chronic Obstructive Pulmonary Disease (COPD) Month. According to St. Lawrence Health, St. Lawrence County has an extremely high number of people with the disease.
St. Lawrence Health seeks local residents for COPD clinical trial northcountrynow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northcountrynow.com Daily Mail and Mail on Sunday newspapers.